Negative in vivo (micronucleus and rat liver UDS), reducing concern over clastogenic signals in vitro
“However, in vivo ceftobiprole medocaril sodium was negative in both the micronucleus assay and rat liver unscheduled DNA synthesis reducing concern for potential clastogenic activity.”
Rat and monkey EFD: no adverse fetal developmental outcomes at ~1.4x and 0.9x MRHD
“Intravenous administration of ceftobiprole medocaril sodium to pregnant rats and monkeys during organogenesis showed no evidence of adverse fetal developmental outcomes at doses approximately 1.4 times and 0.9 times the MRHD, respectively, based on BSA comparison.”
Mouse CNS study: convulsions are a primary CNS effect of ceftobiprole, not secondary to kidney damage
“Ro 63-9141-induced convulsion appears to be a primary effect and not secondary to kidney damage as convulsions were seen with direct injection into the brain.”
Not genotoxic overall: Ames negative; in vitro chromosome aberration positive without (not with) metabolic activation; rat micronucleus and comet negative